Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
4
×
seattle blog main
4
×
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biogen
cancer
cancer immunotherapy
clinical trials
deals
eli lilly
aduro biotech
amgen
What
bio
4
×
roundup
companies
crispr
drug
acquisitions
albert
alliance
approval
biggest
biogen’s
biopharmaceutical
black
bourla
bristol
buy
calls
ceo
changing
color
company
continue
convo
days
debut
diamond
diamond’s
earlier
failures
future
growing
hours
imports
indication
kudos
leading
leaves
life
littered
maker
Language
unset
unknown
Current search:
glaxosmithkline
×
startups
×
" san francisco top stories "
×
bio
×
" seattle blog main "
×
" alzheimer's disease "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More